RETRACTED ARTICLE: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Overview of attention for article published in Stem Cell Research & Therapy, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 12 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 76,513 followers.

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-P... https://t.co/yfaZEua1Kn

13 Mar 2018

Reply Repost Favourite

RT @DanielJDrucker: Alreadt thinkin about the 2019 Academy awards? Nominated for best short: Azoramide, a GLP-R agonist, favors adipogenesi…

11 Mar 2018

Reply Repost Favourite

Alreadt thinkin about the 2019 Academy awards? Nominated for best short: Azoramide, a GLP-R agonist, favors adipogenesis by inhibiting the GLP-1 R pathway. Guest appearance, a GLP-R antibody from Ruiying Biological https://t.co/mF2Fy57Kak #

11 Mar 2018

Reply Repost Favourite

Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway.: Related Articles Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1… https

11 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.